Pharmacists’ perspectives on potential pharmacist prescribing: a nationwide survey in the Netherlands

Bilge Kaymakci, Daphne Philbert, Ankie C.M. Hazen, Mette Heringa, Henk Frans Kwint, Dorien L.M. Zwart, Liset van Dijk, Sofia Kälvemark Sporrong, Thomas G.H. Kempen*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Background: Pharmacist prescribing legislation aims to enhance healthcare quality and accessibility. However, in many countries, like the Netherlands, it has not yet been legally established. Aim: To investigate pharmacists’ perspectives on potential pharmacist prescribing in the Netherlands. Method: An online survey using a questionnaire that was distributed via e-mail and electronic newsletters to most practicing pharmacists in the Netherlands during October and November 2023. The questionnaire was based on previous literature, further developed during an international conference with pharmacists and piloted with Dutch pharmacists. Agreement with statements about potential prescribing models, settings, preconditions, and perceived benefits and risks was measured using a 4-point Likert scale. Data were analysed descriptively. Results: In total, 625 participants from community pharmacy (n = 432; 69.1%), hospital pharmacy (n = 149; 23.8%), or other/combined settings (n = 44; 7.0%) completed the questionnaire. Most pharmacists (somewhat) agreed with the introduction of an independent prescribing model with limitations (n = 538; 86.1%) or a model dependent on collaborative agreements with physicians (n = 471; 75.4%). A minority (n = 245; 39.2%) supported independent prescribing with diagnostic authority. The precondition that participants most frequently (somewhat) agreed with was access to health records (n = 607; 97.1%). The most (somewhat) agreed-upon benefits were enhanced professional position of pharmacists (n = 574; 91.8%) and reduced workload for other prescribers (n = 573; 91.7%). Increased workload for pharmacists (n = 495; 79.2%) was the most (somewhat) agreed-upon identified risk. Conclusion: Pharmacists in the Netherlands are generally supportive of an independent but limited or collaborative pharmacist prescribing model. These findings support further investigations into the potential introduction of pharmacist prescribing legislation.

Original languageEnglish
Article numbere2421993
Pages (from-to)392–402
Number of pages11
JournalInternational Journal of Clinical Pharmacy
Volume47
Issue number2
Early online date1 Dec 2024
DOIs
Publication statusPublished - 2025

Bibliographical note

Publisher Copyright:
© The Author(s) 2024.

Funding

We thank all the pharmacists who took time and participated in the survey. We also extend our gratitude to the pilot group, the Swedish students that were involved in developing the first pilot version and the PCNE workshop participants. Finally, we would like to thank Maren Schilling for the graphical design support.

FundersFunder number
Elisabeth and Alfred Ahlqvist foundation (SE)

    Keywords

    • Drug prescribing
    • Health policy
    • Non-medical prescribing
    • Pharmacists
    • Surveys and questionnaires
    • Task shifting

    Fingerprint

    Dive into the research topics of 'Pharmacists’ perspectives on potential pharmacist prescribing: a nationwide survey in the Netherlands'. Together they form a unique fingerprint.

    Cite this